Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06048081
Title Early Access Program for Zolbetuximab
Recruitment Available
Gender both
Phase Expanded access
Variant Requirements No
Sponsors Astellas Pharma Global Development, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | ESP | DEU | CHE

Facility Status City State Zip Country Details
Site US10001 Morristown New Jersey 07960 United States Details
DE49020 Berlin Germany Details
DE49021 Chemnitz Germany Details
DE49004 Damme Germany Details
DE49006 Erkelenz Germany Details
DE49017 Frankfurt am Main Germany Details
DE49003 Goettingen Germany Details
DE49007 Hamburg Germany Details
DE49022 Kempten Germany Details
DE49008 Kiel Germany Details
DE49024 Kiel Germany Details
DE49023 Koblenz Germany Details
DE49019 Magdeburg Germany Details
DE49010 Munich Germany Details
DE 49005 München Germany Details
DE49012 Nuernberg Germany Details
DE49025 Ravensburg Germany Details
DE49032 Thuine Germany Details
DE49001 Tübingen Germany Details
DE49002 Ulm Germany Details
DE49011 Viersen Germany Details
DE49016 Wiesbaden Germany Details
ESP0344 San Cristobal De La Laguna Santa Cruz De Tenerife Spain Details
CHE0080 Zurich Switzerland Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field